Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Comparison of virus shedding after lived attenuated and pentavalent reassortant rotavirus vaccine.

Hsieh YC, Wu FT, Hsiung CA, Wu HS, Chang KY, Huang YC.

Vaccine. 2014 Feb 26;32(10):1199-204. doi: 10.1016/j.vaccine.2013.08.041. Epub 2013 Sep 24.

PMID:
24076325
2.

Rotavirus shedding in premature infants following first immunization.

Smith CK, McNeal MM, Meyer NR, Haase S, Dekker CL.

Vaccine. 2011 Oct 19;29(45):8141-6. doi: 10.1016/j.vaccine.2011.08.028. Epub 2011 Aug 19.

PMID:
21856359
3.

Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine.

Yen C, Jakob K, Esona MD, Peckham X, Rausch J, Hull JJ, Whittier S, Gentsch JR, LaRussa P.

Vaccine. 2011 May 31;29(24):4151-5. doi: 10.1016/j.vaccine.2011.03.074. Epub 2011 Apr 6.

4.

The integrated phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine.

Dennehy PH, Goveia MG, Dallas MJ, Heaton PM.

Int J Infect Dis. 2007 Nov;11 Suppl 2:S36-42. doi: 10.1016/S1201-9712(07)60020-4.

5.

Detection of PCV-2 DNA in stool samples from infants vaccinated with RotaTeq®.

Esona MD, Mijatovic-Rustempasic S, Yen C, Parashar UD, Gentsch JR, Bowen MD, LaRussa P.

Hum Vaccin Immunother. 2014;10(1):25-32. doi: 10.4161/hv.26731. Epub 2013 Oct 8.

7.

Identification of strains of RotaTeq rotavirus vaccine in infants with gastroenteritis following routine vaccination.

Donato CM, Ch'ng LS, Boniface KF, Crawford NW, Buttery JP, Lyon M, Bishop RF, Kirkwood CD.

J Infect Dis. 2012 Aug 1;206(3):377-83. doi: 10.1093/infdis/jis361. Epub 2012 May 21.

8.

Vaccines for preventing rotavirus diarrhoea: vaccines in use.

Soares-Weiser K, Maclehose H, Bergman H, Ben-Aharon I, Nagpal S, Goldberg E, Pitan F, Cunliffe N.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD008521. doi: 10.1002/14651858.CD008521.pub3. Review.

PMID:
23152260
9.
10.

Real-time RT-PCR assays to differentiate wild-type group A rotavirus strains from Rotarix(®) and RotaTeq(®) vaccine strains in stool samples.

Gautam R, Esona MD, Mijatovic-Rustempasic S, Ian Tam K, Gentsch JR, Bowen MD.

Hum Vaccin Immunother. 2014;10(3):767-77. Epub 2013 Dec 16.

11.

Horizontal transmission of a human rotavirus vaccine strain--a randomized, placebo-controlled study in twins.

Rivera L, Peña LM, Stainier I, Gillard P, Cheuvart B, Smolenov I, Ortega-Barria E, Han HH.

Vaccine. 2011 Nov 28;29(51):9508-13. doi: 10.1016/j.vaccine.2011.10.015. Epub 2011 Oct 18.

12.

Rotavirus vaccines: viral shedding and risk of transmission.

Anderson EJ.

Lancet Infect Dis. 2008 Oct;8(10):642-9. doi: 10.1016/S1473-3099(08)70231-7. Review.

PMID:
18922486
13.

Vaccine-acquired rotavirus in infants with severe combined immunodeficiency.

Patel NC, Hertel PM, Estes MK, de la Morena M, Petru AM, Noroski LM, Revell PA, Hanson IC, Paul ME, Rosenblatt HM, Abramson SL.

N Engl J Med. 2010 Jan 28;362(4):314-9. doi: 10.1056/NEJMoa0904485.

14.

Vaccine-derived human-bovine double reassortant rotavirus in infants with acute gastroenteritis.

Hemming M, Vesikari T.

Pediatr Infect Dis J. 2012 Sep;31(9):992-4. doi: 10.1097/INF.0b013e31825d611e.

PMID:
22581224
15.

A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix.

Nakagomi T, Nakagomi O.

Expert Opin Biol Ther. 2009 Aug;9(8):1073-86. doi: 10.1517/14712590903103787. Review.

PMID:
19591630
16.

A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children.

Dang DA, Nguyen VT, Vu DT, Nguyen TH, Nguyen DM, Yuhuan W, Baoming J, Nguyen DH, Le TL; Rotavin-M1 Vaccine Trial Group.

Vaccine. 2012 Apr 27;30 Suppl 1:A114-21. doi: 10.1016/j.vaccine.2011.07.118.

PMID:
22520120
17.

Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation.

Clark HF, Burke CJ, Volkin DB, Offit P, Ward RL, Bresee JS, Dennehy P, Gooch WM, Malacaman E, Matson D, Walter E, Watson B, Krah DL, Dallas MJ, Schödel F, Kaplan kM, Heaton P.

Pediatr Infect Dis J. 2003 Oct;22(10):914-20.

PMID:
14551493
18.

Experience of pentavalent human-bovine reassortant rotavirus vaccine among healthy infants in Taiwan.

Chang CC, Chang MH, Lin TY, Lee HC, Hsieh WS, Lee PI.

J Formos Med Assoc. 2009 Apr;108(4):280-5. doi: 10.1016/S0929-6646(09)60067-X.

19.

Lack of nonspecific protection against all-cause nonrotavirus gastroenteritis by vaccination with orally administered rotavirus vaccine.

Grant L, Watt J, Moulton L, Weatherholtz R, Reid R, Santosham M, O'Brien K.

J Pediatr Gastroenterol Nutr. 2013 Jun;56(6):635-40. doi: 10.1097/MPG.0b013e318287c5cc.

PMID:
23343932
20.

Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States.

Wang FT, Mast TC, Glass RJ, Loughlin J, Seeger JD.

Pediatr Infect Dis J. 2013 Mar;32(3):278-83. doi: 10.1097/INF.0b013e318275328f.

PMID:
23014356
Items per page

Supplemental Content

Write to the Help Desk